Nectin-4 cis-interacts with ErbB2 and its trastuzumab-resistant splice variants, enhancing their activation and DNA synthesis
出版年份 2019 全文链接
标题
Nectin-4 cis-interacts with ErbB2 and its trastuzumab-resistant splice variants, enhancing their activation and DNA synthesis
作者
关键词
-
出版物
Scientific Reports
Volume 9, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-12-12
DOI
10.1038/s41598-019-55460-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nectin-4 promotes gastric cancer progression via the PI3K/AKT signaling pathway
- (2018) Yan Zhang et al. HUMAN PATHOLOGY
- Cell clustering mediated by the adhesion protein PVRL4 is necessary for α6β4 integrin–promoted ferroptosis resistance in matrix-detached cells
- (2018) Caitlin W. Brown et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nectin-4 is a breast cancer stem cell marker that induces WNT/β-catenin signaling via Pi3k/Akt axis
- (2017) Sumit Siddharth et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway
- (2017) Masahiro Maruoka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nectin-like molecule-4/cell adhesion molecule 4 inhibits the ligand-induced dimerization of ErbB3 with ErbB2
- (2017) Kiyohito Mizutani et al. Scientific Reports
- HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance
- (2017) et al. Cancers
- Nectin spot: a novel type of nectin-mediated cell adhesion apparatus
- (2016) K. Mizutani et al. BIOCHEMICAL JOURNAL
- A novel PI3K/AKT signaling axis mediates Nectin-4-induced gallbladder cancer cell proliferation, metastasis and tumor growth
- (2016) Yijian Zhang et al. CANCER LETTERS
- Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models
- (2016) P. M. Challita-Eid et al. CANCER RESEARCH
- EGFR Dynamics Change during Activation in Native Membranes as Revealed by NMR
- (2016) Mohammed Kaplan et al. CELL
- The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment
- (2016) J Turpin et al. ONCOGENE
- Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer
- (2015) Satoshi Nishiwada et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
- (2015) Sandra M. Swain et al. NEW ENGLAND JOURNAL OF MEDICINE
- miR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer
- (2015) DONGLI ZHAO et al. ONCOLOGY REPORTS
- The Cell Adhesion Molecule Necl-4/CADM4 Serves as a Novel Regulator for Contact Inhibition of Cell Movement and Proliferation
- (2015) Shota Yamana et al. PLoS One
- Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab
- (2014) L. Castagnoli et al. CANCER RESEARCH
- The EGFR Family: Not So Prototypical Receptor Tyrosine Kinases
- (2014) M. A. Lemmon et al. Cold Spring Harbor Perspectives in Biology
- Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice Variant
- (2013) A. Alajati et al. CANCER RESEARCH
- Oncolytic measles virus strains as novel anticancer agents
- (2013) Pavlos Msaouel et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The ErbB/HER family of protein-tyrosine kinases and cancer
- (2013) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Molecular Mechanisms of SH2- and PTB-Domain-Containing Proteins in Receptor Tyrosine Kinase Signaling
- (2013) M. J. Wagner et al. Cold Spring Harbor Perspectives in Biology
- A role for PVRL4-driven cell–cell interactions in tumorigenesis
- (2013) Natalya N Pavlova et al. eLife
- p95HER2 and Breast Cancer
- (2011) J. Arribas et al. CANCER RESEARCH
- The Human Splice Variant Δ16HER2 Induces Rapid Tumor Onset in a Reporter Transgenic Mouse
- (2011) Cristina Marchini et al. PLoS One
- Nectin 4 Overexpression in Ovarian Cancer Tissues and Serum
- (2010) Melissa S. DeRycke et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Clinical Benefit of Lapatinib-Based Therapy in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Tumors Coexpressing the Truncated p95HER2 Receptor
- (2010) M. Scaltriti et al. CLINICAL CANCER RESEARCH
- Identification of Nectin-4 Oncoprotein as a Diagnostic and Therapeutic Target for Lung Cancer
- (2009) A. Takano et al. CANCER RESEARCH
- Strongly Enhanced Antitumor Activity of Trastuzumab and Pertuzumab Combination Treatment on HER2-Positive Human Xenograft Tumor Models
- (2009) W. Scheuer et al. CANCER RESEARCH
- Silencing of ErbB3/ErbB2 Signaling by Immunoglobulin-like Necl-2
- (2009) Satoshi Kawano et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance
- (2009) D. Mitra et al. MOLECULAR CANCER THERAPEUTICS
- Structure-Based View of Epidermal Growth Factor Receptor Regulation
- (2008) Kathryn M. Ferguson Annual Review of Biophysics
- The Immunoglobulin-Like Cell Adhesion Molecule Nectin and Its Associated Protein Afadin
- (2008) Yoshimi Takai et al. Annual Review of Cell and Developmental Biology
- The ERBB3 receptor in cancer and cancer gene therapy
- (2008) G Sithanandam et al. CANCER GENE THERAPY
- Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation
- (2008) Yoshimi Takai et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started